These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 9125203)
1. Type II protein kinase A up-regulation is sufficient to induce growth inhibition in SK-N-SH human neuroblastoma cells. Kim SN; Lee GR; Hwang ES; Lee JH; Park SD; Cho-Chung YS; Hong SH Biochem Biophys Res Commun; 1997 Mar; 232(2):469-73. PubMed ID: 9125203 [TBL] [Abstract][Full Text] [Related]
2. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein. Nesterova M; Noguchi K; Park YG; Lee YN; Cho-Chung YS Clin Cancer Res; 2000 Sep; 6(9):3434-41. PubMed ID: 10999726 [TBL] [Abstract][Full Text] [Related]
3. Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells. Kim SN; Kim SG; Park SD; Cho-Chung YS; Hong SH J Cell Physiol; 2000 Mar; 182(3):421-8. PubMed ID: 10653609 [TBL] [Abstract][Full Text] [Related]
4. An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells. Yokozaki H; Budillon A; Tortora G; Meissner S; Beaucage SL; Miki K; Cho-Chung YS Cancer Res; 1993 Feb; 53(4):868-72. PubMed ID: 8428367 [TBL] [Abstract][Full Text] [Related]
6. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation. Cho YS; Kim MK; Tan L; Srivastava R; Agrawal S; Cho-Chung YS Clin Cancer Res; 2002 Feb; 8(2):607-14. PubMed ID: 11839683 [TBL] [Abstract][Full Text] [Related]
7. Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy. Cho YS; Cho-Chung YS Clin Cancer Res; 2003 Mar; 9(3):1171-8. PubMed ID: 12631623 [TBL] [Abstract][Full Text] [Related]
8. Cyclic AMP-dependent protein kinase (cAK) in human B cells: co-localization of type I cAK (RI alpha 2 C2) with the antigen receptor during anti-immunoglobulin-induced B cell activation. Levy FO; Rasmussen AM; Taskén K; Skålhegg BS; Huitfeldt HS; Funderud S; Smeland EB; Hansson V Eur J Immunol; 1996 Jun; 26(6):1290-6. PubMed ID: 8647207 [TBL] [Abstract][Full Text] [Related]
9. Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors. Tortora G; Ciardiello F; Damiano V; Pepe S; Bianco C; di Isernia G; Davies SL; North P; Harris AL; Hickson ID Clin Cancer Res; 1995 Jan; 1(1):49-56. PubMed ID: 9815886 [TBL] [Abstract][Full Text] [Related]
10. Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway. Alper O; Hacker NF; Cho-Chung YS Oncogene; 1999 Sep; 18(35):4999-5004. PubMed ID: 10490835 [TBL] [Abstract][Full Text] [Related]
11. Chemoprevention with protein kinase A RIalpha antisense in DMBA-mammary carcinogenesis. Nesterova MV; Cho-Chung YS Ann N Y Acad Sci; 2005 Nov; 1058():255-64. PubMed ID: 16394142 [TBL] [Abstract][Full Text] [Related]
12. Antisense protein kinase A RIalpha inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer: blockade at the initial phase of carcinogenesis. Nesterova MV; Cho-Chung YS Clin Cancer Res; 2004 Jul; 10(13):4568-77. PubMed ID: 15240549 [TBL] [Abstract][Full Text] [Related]
13. Flow-cytometric detection of the RI alpha subunit of type I cAMP-dependent protein kinase in human cells. Pepe S; Ruggiero A; Tortora G; Ciardiello F; Garbi C; Yokozaki H; Cho-Chung YS; Clair T; Skalhegg BS; Bianco AR Cytometry; 1994 Jan; 15(1):73-9. PubMed ID: 8162827 [TBL] [Abstract][Full Text] [Related]
14. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy. Nesterova MV; Johnson NR; Stewart T; Abrams S; Cho-Chung YS Clin Cancer Res; 2005 Aug; 11(16):5950-5. PubMed ID: 16115938 [TBL] [Abstract][Full Text] [Related]
15. Regulation of cAMP-dependent protein kinase subunit expression in CATH.a and SH-SY5Y cells. Boundy VA; Chen J; Nestler EJ J Pharmacol Exp Ther; 1998 Aug; 286(2):1058-65. PubMed ID: 9694969 [TBL] [Abstract][Full Text] [Related]
16. Thyroid-stimulating hormone-regulated growth and cell cycle distribution of thyroid cells involve type I isozyme of cyclic AMP-dependent protein kinase. Tortora G; Pepe S; Cirafici AM; Ciardiello F; Porcellini A; Clair T; Colletta G; Cho-Chung YS; Bianco AR Cell Growth Differ; 1993 May; 4(5):359-65. PubMed ID: 8518230 [TBL] [Abstract][Full Text] [Related]
17. Regulation of P-glycoprotein expression in cyclic AMP-dependent protein kinase mutants. Cvijic ME; Chin KV Cell Growth Differ; 1997 Dec; 8(12):1243-7. PubMed ID: 9419412 [TBL] [Abstract][Full Text] [Related]
18. Nuclear translocation of the catalytic subunit of protein kinase A induced by an antisense oligonucleotide directed against the RIalpha regulatory subunit. Neary CL; Cho-Chung YS Oncogene; 2001 Nov; 20(55):8019-24. PubMed ID: 11753685 [TBL] [Abstract][Full Text] [Related]
19. Isozymes of cyclic AMP-dependent protein kinases (PKA) in human lymphoid cell lines: levels of endogenous cAMP influence levels of PKA subunits and growth in lymphoid cell lines. Skålhegg BS; Johansen AK; Levy FO; Andersson KB; Aandahl EM; Blomhoff HK; Hansson V; Taskén K J Cell Physiol; 1998 Oct; 177(1):85-93. PubMed ID: 9731748 [TBL] [Abstract][Full Text] [Related]
20. Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RIalpha subunit. Nesterova M; Cho-Chung YS Antisense Nucleic Acid Drug Dev; 2000 Dec; 10(6):423-33. PubMed ID: 11198926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]